Search

“thermodox”

More pages from the web

1–2 of 2

theoptionhunter.blogspot.com
Option Hunter

Option Hunter The right trade at the right time. Tuesday, November 27, 2012 Celsion (CLSN) - Phase III Drug Trials for ThermoDox CLSN closed at $7.58, down 2.8% with the 30 day Implied Volatility unchanged at 135. Celsion is an oncology drug development corporation focused on the development and commercialization of treatments for those suffering from different forms of cancer. The company is currently having its Phase III clinical trial for ThermoDox, a potential treatment
- option
- drug
- development
- thermodox
- iii
Profile Edit this listing
celsion.com
Celsion Corporation

Mission statement Management team Board of directors Governance Scientific Advisors Contact us About our products Product Pipeline Our technology in action LTSL Brochure CEO letter Stock information Financial information Shareholder tools News releases E
- technology
Profile Edit this listing